Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-27 @ 11:37 AM
Study NCT ID:
NCT00220233
Status:
COMPLETED
Last Update Posted:
2018-12-24
First Post:
2005-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olmesartan as an add-on to Amlodipine in Hypertension
Sponsor:
Sankyo Pharma Gmbh
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Essential Hypertension | View |
Keywords: